Andrew Cordssen-David
CEO
Andrew Cordssen-David is the CEO and co-founder of HeadFirst Inc., a medical device company focused on revolutionizing concussion detection through rapid, saliva-based screening tools. With a strong background in biotechnology, Andrew combines his scientific expertise with entrepreneurial vision to lead HeadFirst in developing innovative diagnostic solutions that enhance safety for athletes and individuals at risk of concussions.
A former university and semi-professional hockey player, Andrew’s passion for concussion prevention stems from his personal experience with brain injuries, driving his commitment to improving concussion management. Under his leadership, HeadFirst aims to empower medical professionals and athletic trainers with quick, reliable results, ensuring the immediate and objective detection of concussions on the sidelines of the playing field.
Andrew has successfully steered HeadFirst through research and development, securing partnerships, and preparing for commercialization. With a focus on leveraging biomarkers for faster diagnosis, Andrew and his team are dedicated to advancing concussion care in Canada and beyond. HeadFirst is now positioned to make a lasting impact in both the sports and medical communities by bringing accessible, accurate concussion screening technology to the forefront.